Market Research Reports | 24 June 2024 | News
The Evolution of the Pharmaceutical Landscape: A Two-Decade Journey of Mergers and Acquisitions
The following report provides detailed analysis of Mergers and Acquisitions of BioPharma and Pharmaceuticals c...Read more
Industry Insights | 04 June 2024 | News
Navigating Turbulent Waters: How Workforce Reductions Reflect Broader Industry Trends
A Shifting Landscape: The Bio Industry's May 2024 Layoffs May 2024 witnessed a wave of layoffs across the bio...Read more
Thailand | 31 May 2024 | Opinion
How Thai Biotech and Healthtech is Thriving with Innovations
The government's commitment to foster innovation and technological advancement is one of the driving forces be...Read more
China | 31 May 2024 | Opinion
“There’s a growing focus on developing novel ADCs tailored to address unmet medical needs”
Can you provide an overview of Nona Biosciences' integrated antibody discovery services? Nona Biosciences is ...Read more
Taiwan | 31 May 2024 | Analysis
Taiwan’s Pursuit of Precision Med Excellence Intensifies
The Taiwan National Development Council identified the precision health industry as one of its six strategic i...Read more
Pharma | 28 May 2024 | Opinion
"Integrating process data poses several significant challenges in biomanufacturing"
What are the key highlights & advantages of the Bio4C Process Pad? How does it benefit the biopharma indus...Read more
Japan | 24 June 2024 | News
Japan approves first post-transplant anti- cytomegalovirus infection treatment
Takeda Pharma has announced that LIVTENCITY (maribavir) has been approved by the Japanese Ministry o...Read more
China | 17 June 2024 | News
AbbVie inks deal worth $1.56 B with China's FutureGen to develop IBD therapy
US-based firm AbbVie and FutureGen Biopharmaceutical (Beijing) have announced a license agreement to develop F...Read more
Vietnam | 14 June 2024 | News
Lupin partners with Fuji to strengthen women's health portfolio in Vietnam and Philippines
India-headquartered pharma major Lupin has signed a license and supply agreement with OLIC (Thailand), a subsi...Read more
China | 21 June 2024 | News
Hong Kong develops innovative mRNA drug for treatment of nasopharyngeal carcinoma
Nasopharyngeal carcinoma (NPC) is a cancer type strongly associated with Epstein-Barr virus (EBV) infection. T...Read more
Australia | 18 June 2024 | News
New biotech company in Australia to tackle hard-to-treat cancers
A new biotech company launched on 18th June in Australia will use a world-leading technology to target cancers...Read more
Singapore | 13 June 2024 | News
NSG BioLabs and Eppendorf Group partner to support biotech companies in Singapore
NSG BioLabs, Singapore's largest provider of biotech co-working laboratory and office space, has ann...Read more
Thailand | 25 June 2024 | News
Chinese medical aesthetic player Singclean to launch products in Thailand
Singclean, a global player and a leading Chinese manufacturer of high-quality medical aesthetic products, anno...Read more
Japan | 18 June 2024 | News
Mirxes secures grant of S$172k to develop novel cancer screening test in Japan
Singapore-based startup Mirxes has announce that its fully-owned subsidiary, Mirxes Japan, has secured a grant...Read more
Indonesia | 13 June 2024 | News
SS Innovations' Mantra surgical robotic system receives approval for use in Indonesia
Indian firm SS Innovations International, Inc. (SSII), a developer of innovative surgical robotic technologies...Read more
China | 26 June 2024 | News
Porton Advanced introduces MaxCyte ExPERT GTx Flow Electroporation instrument for cell therapy
Porton Advanced, a subsidiary of China headquartered contract development and manufacturing organisation (CDMO...Read more
North America | 24 June 2024 | News
Taiwan's Bora Pharma buys US-based Emergent BioSolutions' manufacturing site for $30 M
US-based Emergent BioSolutions Inc. has entered into a definitive agreement to sell its drug product facility ...Read more
New Zealand | 14 June 2024 | News
Novotech launches dedicated early phase unit for biotechs leveraging ANZ clinical environment
Novotech, the global full-service Contract Research Organization (CRO) that partners with biotech companies to...Read more
IPO FEVER GRIPS BIOTECH INDUSTRY
After two tumultuous years marred by geopolitical tensions and recession, the biotech sector IPOs (initial public offering) is showing signs of recovery. Experts are hopeful that this year will revive the public equity markets for biotech companies. Twelve biotech companies have gone public this year, raising a total of nearly $1.5 billion, compared to a total of only nineteen biotech companies, throughout 2023. Are biotech IPOs poised for an upswing? Is the worst finally over for biotech IPOs? Let's find out.